Mari L. DeMarco
TitleCited byYear
From conversion to aggregation: protofibril formation of the prion protein
ML DeMarco, V Daggett
Proceedings of the National Academy of Sciences 101 (8), 2293-2298, 2004
3422004
Unifying features in protein-folding mechanisms
S Gianni, NR Guydosh, F Khan, TD Caldas, U Mayor, GWN White, ...
Proceedings of the National Academy of Sciences 100 (23), 13286-13291, 2003
2632003
Structural glycobiology: a game of snakes and ladders
ML DeMarco, RJ Woods
Glycobiology 18 (6), 426-440, 2008
1412008
Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease
RS Armen, ML DeMarco, DOV Alonso, V Daggett
Proceedings of the National Academy of Sciences 101 (32), 11622-11627, 2004
1232004
Molecular mechanism for low pH triggered misfolding of the human prion protein
ML DeMarco, V Daggett
Biochemistry 46 (11), 3045-3054, 2007
932007
Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models
ML DeMarco, J Silveira, B Caughey, V Daggett
Biochemistry 45 (51), 15573-15582, 2006
902006
Preventing misfolding of the prion protein by trimethylamine N-oxide
BJ Bennion, ML DeMarco, V Daggett
Biochemistry 43 (41), 12955-12963, 2004
872004
Extension of the GLYCAM06 biomolecular force field to lipids, lipid bilayers and glycolipids
MB Tessier, ML DeMarco, AB Yongye, RJ Woods
Molecular simulation 34 (4), 349-364, 2008
802008
Local environmental effects on the structure of the prion protein
ML DeMarco, V Daggett
Comptes rendus biologies 328 (10-11), 847-862, 2005
632005
Diafiltration MALDI-TOF mass spectrometry method for culture-independent detection and identification of pathogens directly from urine specimens
ML DeMarco, CAD Burnham
American Journal of Clinical Pathology 141 (2), 204-212, 2014
572014
Atomic-resolution conformational analysis of the GM3 ganglioside in a lipid bilayer and its implications for ganglioside–protein recognition at membrane surfaces
ML DeMarco, RJ Woods
Glycobiology 19 (4), 344-355, 2008
572008
Beyond identification: emerging and future uses for MALDI-TOF mass spectrometry in the clinical microbiology laboratory
ML DeMarco, BA Ford
Clinics in laboratory medicine 33 (3), 611-628, 2013
512013
Presentation of membrane-anchored glycosphingolipids determined from molecular dynamics simulations and NMR paramagnetic relaxation rate enhancement
ML DeMarco, RJ Woods, JH Prestegard, F Tian
Journal of the American Chemical Society 132 (4), 1334-1338, 2010
492010
Biomarker development for chronic obstructive pulmonary disease. From discovery to clinical implementation
DD Sin, Z Hollander, ML DeMarco, BM McManus, RT Ng
American journal of respiratory and critical care medicine 192 (10), 1162-1170, 2015
392015
From agonist to antagonist: Structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxins
ML DeMarco, RJ Woods
Molecular immunology 49 (1-2), 124-133, 2011
382011
Diffusing and colliding: the atomic level folding/unfolding pathway of a small helical protein
ML DeMarco, DOV Alonso, V Daggett
Journal of molecular biology 341 (4), 1109-1124, 2004
372004
Characterization of cell‐surface prion protein relative to its recombinant analogue: insights from molecular dynamics simulations of diglycosylated, membrane‐bound human prion …
ML DeMarco, V Daggett
Journal of neurochemistry 109 (1), 60-73, 2009
362009
Three-dimensional structure of glycolipids in biological membranes
ML DeMarco
Biochemistry 51 (29), 5725-5732, 2012
202012
Biomarker development in COPD: moving from P values to products to impact patient care
Z Hollander, ML DeMarco, M Sadatsafavi, BM McManus, RT Ng, DD Sin
Chest 151 (2), 455-467, 2017
192017
Resolution of spurious immunonephelometric IgG subclass measurement discrepancies by LC-MS/MS
G van der Gugten, ML DeMarco, LYC Chen, A Chin, M Carruthers, ...
Clinical chemistry 64 (4), 735-742, 2018
122018
The system can't perform the operation now. Try again later.
Articles 1–20